When Is a Bronchiectasis Flare-Up an Emergency? How Exacerbations Are Treated

The change is often small enough to argue with yourself about. The morning cough that usually clears in ten minutes drags on for thirty. The sputum in the pot looks darker, greener, thicker than it did last week. By Wednesday the stairs feel steeper, and by Thursday you are tired in a way that sleep does not fix. Anyone who lives with bronchiectasis knows this drift, and knows the two questions that arrive with it: is this a flare-up, and if so, how urgent is it?

Those two questions deserve separate answers. Most flare-ups are managed at home with a planned approach that respiratory guidelines describe in detail. A minority tip into emergencies, and the warning signs for that are specific and learnable. This article walks through bronchiectasis flare up treatment as the evidence describes it, from the first sputum sample to the two-week mark, and is clear about where the evidence is thin.

Nothing here replaces your own respiratory team, who know your lung scans, your culture history and your baseline. What it can do is help you recognize what they are weighing, and why.

What a bronchiectasis flare-up actually is, and how doctors define one

Bronchiectasis is a condition in which some of the airways in the lungs have become permanently widened and scarred, so they trap mucus instead of clearing it. That trapped mucus is a comfortable home for bacteria. The immune system responds by sending neutrophils, a type of white blood cell, which release enzymes that damage the airway wall further. Respiratory specialists call this the vicious cycle: infection, inflammation, damage, more trapped mucus, more infection.

A flare-up is what happens when that cycle accelerates. Bacterial numbers climb, inflammation surges, and the airways produce more and thicker mucus than the daily clearance routine can shift. The British Thoracic Society guideline adopts an international consensus definition: a person with bronchiectasis has an exacerbation when three or more of six key symptoms worsen for at least 48 hours, and a clinician judges that a change in treatment is needed. The six are cough, sputum volume or consistency, sputum purulence (how pus-like it is), breathlessness or reduced exercise tolerance, fatigue or malaise, and coughing up blood.

The 48-hour part of that definition matters more than it looks. Everyone with bronchiectasis has bad days. A single afternoon of heavier cough after a dusty walk is not an exacerbation, and treating every bad day with antibiotics would drive resistance without helping. What defines a flare is a sustained shift across several symptoms at once.

The other half of the definition, the clinician judging that treatment should change, is why self-diagnosis is not the goal here. Your job is to notice the pattern and report it early. Your team’s job is to decide whether it meets the threshold, and what to do about it.

What does a bronchiectasis flare up feel like? Bronchiectasis exacerbation symptoms explained

People who have lived through several flares tend to describe the same order of events, though the details vary. The sputum usually changes first. It darkens from pale to yellow to green, sometimes with a brownish tinge, and becomes stickier and harder to move. Volume often rises: a person who fills a small pot most mornings may find it filling twice, or find themselves coughing productively through the afternoon when they normally would not.

The cough itself changes character. It becomes more frequent and more effortful, and it can disturb sleep, which feeds the fatigue that so many people say is the worst part. That tiredness is not laziness or deconditioning; it is the systemic cost of a body fighting an infection and doing extra respiratory work around the clock.

Breathlessness creeps in on tasks that were fine a week earlier. Some people notice wheeze or chest tightness, particularly if they also have asthma or chronic obstructive pulmonary disease (COPD), a lung condition that narrows the airways. A dull ache in the chest wall from repeated coughing is common. Streaks of blood in the sputum can appear, because inflamed airway walls bleed easily.

Fever is less universal than people expect. The NHS and Cleveland Clinic both list it among possible signs, but many exacerbations run without a high temperature, especially in older adults. Its absence does not rule a flare out.

None of this is a checklist to score yourself against. A viral cold, heart problems and even a change in medication can mimic parts of the picture. What the description offers is a vocabulary. When you call your team and can say that your sputum has been darker and doubled in volume for three days, that your stairs test has fallen from two flights to one, and that you are sleeping badly from cough, you have handed them most of what they need to decide whether this meets the exacerbation definition.

When is a bronchiectasis flare-up an emergency?

Most exacerbations are urgent rather than emergent: they need a same-week assessment and a treatment decision, not an ambulance. A smaller group crosses a line where the lungs can no longer keep oxygen levels up or clear carbon dioxide, or where bleeding becomes dangerous. Recognizing that line is the single most useful skill this article can offer.

Respiratory guidelines describe the features that push clinicians toward hospital admission, and they double as the emergency warning signs. Severe breathlessness that persists at rest, and a breathing rate of 25 or more breaths per minute, appear in the British Thoracic Society admission criteria. So do cyanosis, a bluish or grayish color of the lips, tongue or fingertips that signals low blood oxygen, and new confusion or unusual drowsiness, which can mean carbon dioxide is building up. A temperature of 38°C (100.4°F) or higher, signs of circulatory trouble such as a racing pulse with cold, clammy skin, and failure to improve on oral antibiotics round out the list.

Coughing up blood deserves its own line. Small streaks in sputum are common during flares and usually settle as the infection is treated. Large-volume bleeding is different. The NHS describes massive hemoptysis as coughing up more than 100 milliliters of blood, roughly a third of a standard drinks can, within 24 hours, and advises calling emergency services. Blood that keeps coming, or that is accompanied by lightheadedness or breathlessness, should be treated the same way even if you have not measured it.

The emergency call is not an admission of failure, and it is not the same as deciding you need to stay in hospital. Emergency clinicians can give oxygen, start intravenous antibiotics, control bleeding and monitor you while the picture clarifies. Waiting to see whether things settle overnight is the decision that respiratory teams most often wish their patients had not made.

What triggers bronchiectasis flare-ups?

Ask five people with bronchiectasis what set off their last flare and you will hear five different stories, but the underlying triggers cluster into a few groups.

Viral respiratory infections lead the list. A common cold, influenza, respiratory syncytial virus or COVID-19 inflames the airway lining, slows the tiny hair-like cilia that sweep mucus upward, and gives resident bacteria a chance to multiply. Many exacerbations that end up needing antibiotics began as something that felt like an ordinary cold. This is why respiratory teams place so much weight on vaccination, which the NHS and CDC both recommend for people with chronic lung disease.

Bacterial shifts are the second group. The airways of people with bronchiectasis are often chronically colonized, meaning bacteria live there without causing a full-blown infection. The most discussed organisms are Haemophilus influenzae and Pseudomonas aeruginosa. Pseudomonas in particular is associated with more frequent exacerbations and faster decline in lung function in the European Respiratory Society guideline, which is why its first appearance in a culture usually prompts a targeted treatment attempt.

Lapses in airway clearance form the third group, and they are the most controllable. Travel, illness in the family, a busy stretch at work: the daily routine slips for a week, mucus accumulates, and the bacterial load rises. Dehydration thickens mucus and makes clearance harder still.

Environmental and bodily factors make up the rest. Smoke of any kind, high pollution days and cold dry air irritate the airways. Gastro-esophageal reflux, in which stomach acid travels up toward the throat, is more common in bronchiectasis and may reach the airways in small amounts. Poorly controlled asthma or COPD alongside bronchiectasis adds inflammation of its own.

Knowing your personal pattern helps your team more than a generic list does. If your flares reliably follow head colds, the plan for the first day of a sniffle looks different from the plan for someone whose flares appear out of nowhere.

How bronchiectasis flare up treatment works in the first 48 hours

The first two days of a flare set the tone for the rest of it, and the sequence that respiratory guidelines describe is deliberately ordered.

Step one is a sputum sample. Before any antibiotic starts, the British Thoracic Society guideline advises sending a sputum specimen for culture, which means growing whatever bacteria are present in a laboratory and testing which antibiotics they are sensitive to. Antibiotics taken beforehand can suppress growth and produce a misleadingly clean result. The sample is not there to delay treatment; it is there so that if the first antibiotic does not work, the second choice is informed rather than a guess.

Step two is starting an antibiotic empirically, that is, based on the most likely organism rather than waiting for culture results. Your team leans heavily on your previous cultures here. Someone whose last three samples grew Haemophilus will be started on a different class than someone with a history of Pseudomonas, which requires specific anti-pseudomonal agents. The choice, the route and the duration belong to the prescriber.

Step three, and the one most often skipped, is intensifying airway clearance. Antibiotics lower the bacterial load, but they cannot pull plugs of thick mucus out of widened airways. Clearance does that, and during a flare the guidelines expect it to be done more often and for longer than the usual daily routine. A respiratory physiotherapist may adjust technique or add nebulized saline to loosen secretions.

Hydration, rest and keeping any inhalers for coexisting asthma or COPD on schedule fill in the rest. Many teams also arrange a check-in within the first few days, because early failure to improve is one of the criteria that changes the plan toward hospital or intravenous treatment.

Notice what is not in this list: oral steroids, extra inhalers or cough suppressants as routine measures. The reasons for that appear in a later section.

Antibiotics in a bronchiectasis flare: oral, intravenous and the 14-day question

Antibiotics are the backbone of exacerbation treatment because bacterial overgrowth is what drives the inflammatory surge. Reducing the bacterial load calms the neutrophil response, which in turn reduces mucus production and airway swelling. The class chosen depends on the likely organism and on your culture history, and it is the prescribing clinician who makes that call.

Duration is where bronchiectasis differs from a routine chest infection. Both the British Thoracic Society and the European Respiratory Society guidelines recommend a 14-day course for exacerbations, roughly double what many people are used to for bronchitis or a urinary infection. The reasoning is mechanical: damaged, mucus-filled airways are hard for antibiotics to penetrate, and bacterial numbers rebound quickly if the course stops while they are still high. The guidelines acknowledge that shorter courses may be reasonable in milder flares for some people, but 14 days is the reference point, and the decision to shorten sits with your team.

Most exacerbations are treated with oral antibiotics. Intravenous treatment, delivered directly into a vein, is reserved for situations described in the guidelines: severe illness, failure to improve on oral therapy, or organisms that cannot be treated by mouth, which often means Pseudomonas. Intravenous courses were once a guarantee of a hospital bed; many services now deliver them at home or in day units after an initial assessment, where local arrangements allow.

Culture results usually arrive after treatment has begun. If they show the organism is resistant to the antibiotic you are taking, your team may switch. If they show sensitivity and you are improving, nothing changes. If Pseudomonas appears for the first time, both guidelines recommend an attempt to clear it with a targeted regimen, because chronic Pseudomonas is linked to more frequent flares.

Two rules from the guidelines are worth carrying with you. Finish the course unless your prescriber tells you otherwise, even when you feel better by day five. And report a lack of improvement rather than waiting it out, because that is a signal the plan needs to change.

Airway clearance during a flare-up: the part people skip

If antibiotics are the backbone of flare-up treatment, airway clearance is the muscle. It is also the component most likely to be neglected, precisely when it matters most, because a person who is exhausted and breathless does not feel like spending twenty minutes doing breathing exercises three times a day.

The physiology explains why it earns that effort. During an exacerbation, mucus becomes thicker and more abundant, and it pools in the widened airway segments where cilia no longer work well. Bacteria multiply inside those pools, shielded from antibiotics that reach them poorly. Clearance techniques physically move the mucus toward the larger airways, where it can be coughed out. Less mucus means fewer bacteria, better antibiotic penetration and less trapped air.

The techniques themselves are taught by respiratory physiotherapists and vary by person. The active cycle of breathing technique alternates relaxed breathing, deep breaths and a forced exhalation called a huff. Autogenic drainage uses controlled breathing at different lung volumes to shift mucus upward. Positive expiratory pressure devices add resistance to breathing out, which holds airways open and helps dislodge secretions. Postural drainage uses gravity by positioning the body so that affected lung segments sit uppermost. The British Thoracic Society guideline recommends that everyone with bronchiectasis is taught a technique and that it is reviewed and intensified during exacerbations.

Nebulized saline is often paired with clearance. Salt water inhaled as a fine mist draws water into the mucus and loosens it. Hypertonic saline, which is saltier than body fluids, is used by some teams before a clearance session; a trial dose under supervision is usual because it can trigger cough or tightness in some people.

Practical points that physiotherapists repeat: do a session before bed to reduce night cough, drink enough that your mucus is not fighting dehydration, and ask for a review if your usual technique is not moving sputum during the flare. Technique that worked at baseline often needs adjusting when secretions change.

Who is usually treated at home, and who is admitted to hospital

The majority of exacerbations are managed at home. Hospital admission is reserved for people who are severely unwell, who cannot manage safely where they live, or who need treatments that a home setting cannot provide. The British Thoracic Society guideline lists the features that prompt admission, and most respiratory teams use some version of the same list. The table below summarizes the two pathways as the guideline describes them; the final decision always rests with the assessing clinician, who is also weighing your baseline lung function, other conditions and support at home.

Feature	Usually managed at home	Usually prompts hospital assessment or admission
Breathing	Breathless on exertion but comfortable at rest	Breathless at rest, breathing rate of 25 or more per minute
Oxygen and color	Normal color, no new oxygen need	Cyanosis (bluish lips or fingertips), new need for oxygen
Mental state	Alert and oriented	New confusion or drowsiness
Temperature and circulation	Mild or no fever, stable pulse	Temperature of 38°C or above, signs of circulatory failure
Response to treatment	Improving on oral antibiotics	Not improving on oral antibiotics, or intravenous antibiotics needed
Bleeding	Streaks of blood in sputum	Large-volume bleeding, more than 100 ml in 24 hours per the NHS
Practical situation	Able to eat, drink, clear airways and take medicines	Unable to cope at home or lacking support to do so

Two groups sit in the middle and often get a tailored plan. People with chronic Pseudomonas who need intravenous antibiotics but are otherwise stable may be candidates for home intravenous therapy through an outpatient service, where one exists. People with significant heart or kidney disease alongside bronchiectasis may be admitted for monitoring even when their lung symptoms alone would not justify it.

Being asked to wait, in this context, usually means being asked to stay home with a treatment plan and a low threshold to call back. It does not mean nothing is happening.

What the next two weeks usually look like

Recovery from a flare is rarely a straight line, and knowing the usual shape of it prevents unnecessary alarm as well as unnecessary complacency. What follows is the pattern respiratory teams describe for an uncomplicated exacerbation treated at home; your own may differ, and the guidelines do not set a fixed timetable for returning to baseline.

The first three days are about starting treatment and holding steady. Antibiotics take time to lower bacterial numbers, and the airways are still inflamed, so symptoms often stay flat rather than improving. Intensified airway clearance can temporarily bring up more sputum, which is the mucus that was stuck rather than a sign of worsening. Culture results usually come back during this window, which is when a switch in antibiotic happens if one is needed.

From roughly day four onward, most people notice the sputum lightening in color and becoming easier to move. Cough frequency drops. Breathlessness on exertion improves more slowly than the sputum does, and fatigue lags behind everything else; this is the stage when people feel well enough to be frustrated by how tired they still are.

The second week is about consolidation. The 14-day course recommended by the British Thoracic Society and European Respiratory Society guidelines is designed to keep suppressing bacteria while the airway lining recovers. Stopping when the sputum looks normal risks a rebound. Airway clearance continues at the intensified frequency until your team says to step back to your usual routine.

After the course ends, some teams arrange a follow-up sputum sample or a clinic review, especially if this was a first flare, if Pseudomonas appeared, or if flares are becoming more frequent. Lung function and general stamina may take longer to return fully, and a course of pulmonary rehabilitation is sometimes suggested to rebuild it.

A flare that has not begun to improve within the first several days, or that improves and then worsens again before the course finishes, is a reason to contact your team rather than to wait for the end of the antibiotics.

Steroids, inhalers and oxygen: what helps and what usually does not

People arriving with a bronchiectasis flare often expect the treatment package they associate with asthma or COPD: a burst of oral steroids, a stronger inhaler, perhaps oxygen. The evidence for bronchiectasis is different, and the guidelines are candid about it.

Oral corticosteroids, medicines that dampen inflammation broadly, are not recommended as routine treatment for bronchiectasis exacerbations in the British Thoracic Society guideline. The inflammation in bronchiectasis is driven by neutrophils responding to bacteria, and steroids do not address the bacterial cause; they also carry side effects and may blunt the immune response. The exception is people who have asthma or COPD alongside bronchiectasis, in whom a flare of that coexisting condition may warrant steroids on its own merits. Your team decides which condition is driving the current picture.

Inhaled corticosteroids follow the same logic. The guideline does not recommend them for bronchiectasis alone, but they remain part of standard care for coexisting asthma and, in some cases, COPD. If you use one for that reason, a flare is not a reason to stop it.

Bronchodilators, inhalers that relax airway muscle, are useful when wheeze or airflow obstruction is present, and some physiotherapists suggest a dose before airway clearance to open the airways first. They are not a substitute for clearance or antibiotics.

Mucolytics deserve a specific mention because one of them, a recombinant DNase used in cystic fibrosis, is not recommended for bronchiectasis that is not due to cystic fibrosis; the British Thoracic Society guideline notes that trials showed no benefit and possible harm in this group. Nebulized saline, described earlier, is the mucus-thinning approach the guidelines do support as an aid to clearance.

Oxygen is given when blood oxygen levels are measurably low, not for breathlessness on its own. Too much oxygen can be harmful in people who retain carbon dioxide, so the target range is set by the treating team using a pulse oximeter or blood gas measurement. Home oxygen for a flare is not something to arrange on your own initiative.

How to stop bronchiectasis getting worse between flare-ups

Treating the current flare is half the job. The other half is lengthening the gap before the next one, because frequent exacerbations are linked in the European Respiratory Society guideline to faster decline in lung function and poorer quality of life. Several strategies have guideline support.

Daily airway clearance is the foundation, and it is the one most within your control. Doing it on the good days keeps the bacterial load low and the mucus moving. Ask for a physiotherapy review at least annually, or whenever your sputum pattern changes, because techniques and devices can be tuned.

Vaccination reduces the viral triggers that start so many flares. The NHS recommends an annual influenza vaccine and pneumococcal vaccination for people with bronchiectasis, and the CDC includes chronic lung disease among the conditions for which COVID-19 and RSV vaccines are advised for eligible age groups. Your team can confirm which apply to you.

For people with three or more exacerbations a year despite good clearance, the British Thoracic Society guideline supports considering long-term antibiotic treatment. Macrolides, a class taken by mouth that has both antibacterial and anti-inflammatory effects, are one option; inhaled antibiotics are another, particularly for chronic Pseudomonas. Both carry trade-offs, including resistance, hearing and heart-rhythm monitoring for macrolides, and the guideline expects a specialist discussion before either begins.

Treating what lies underneath matters too. Bronchiectasis sometimes has an identifiable cause, such as an immune deficiency, reflux, or a coexisting airway disease, and addressing it can reduce flares. Pulmonary rehabilitation, a supervised exercise and education program, improves stamina and is recommended in the guideline for people limited by breathlessness.

Finally, a written self-management plan, agreed with your team, sets out what to do at the first sign of a flare, including when to send a sputum sample and when to call. Some people keep a standby antibiotic supply at home under such a plan; whether that is appropriate, and what it contains, is entirely a decision for your prescriber.

What people often get wrong about bronchiectasis flare-ups

Several beliefs about exacerbations circulate widely enough that respiratory nurses spend a good part of every clinic correcting them. Here are the ones that cause the most trouble.

Green sputum always means antibiotics. Color is a clue, not a verdict. Sputum can be discolored at baseline in chronic colonization, and the exacerbation definition used by the British Thoracic Society requires several symptoms to worsen for at least 48 hours, not a single change in color. Treating every green day with antibiotics drives resistance.

A short course is fine if I feel better. The 14-day recommendation in both major guidelines exists because bacterial numbers in damaged airways rebound quickly. Feeling better at day five reflects falling inflammation, not cleared infection. Stopping early is one of the commoner reasons a flare returns within weeks.

Steroids will speed things up. For bronchiectasis without coexisting asthma or COPD, guidelines do not support routine oral steroids, and they can suppress the immune response you need. This surprises people who have watched relatives with COPD receive steroids for every flare.

Airway clearance can wait until I have more energy. Reversed logic. Clearance is most valuable during a flare, when mucus is thickest and bacterial load highest. Shorter, more frequent sessions are a reasonable compromise when energy is low; skipping is not.

Blood in sputum is always an emergency. Streaks are common in flares because inflamed airway walls bleed easily, and they usually settle with treatment. Large volumes, which the NHS defines as more than 100 milliliters in 24 hours, or bleeding with dizziness or breathlessness, are the emergency.

Bronchiectasis is rare, so my doctor will not know it. It is less common than asthma or COPD, but it is a recognized condition with detailed international guidelines, and most respiratory services manage it routinely.

If I feel fine, my lungs are fine. Chronic colonization can be silent while damage progresses, which is why routine sputum surveillance and clinic reviews continue between flares.

Questions to ask your care team about flare-up treatment

A flare-up appointment, whether in person or by phone, tends to be short, and the useful questions are the ones that shape what you do at home afterward. These are the ones respiratory clinicians say they wish more people asked.

• Does what I am describing meet the definition of an exacerbation, or should we watch it for another day or two before treating?
• Do you want a sputum sample before I start the antibiotic, and how should I collect and deliver it?
• What organism are you treating for, based on my previous cultures, and what will change if the new culture shows something different?
• How long is this antibiotic course, and what should I do if I feel completely well before it ends?
• How many airway clearance sessions a day should I aim for during this flare, and should I change my technique or add nebulized saline?
• What specific signs mean I should call you back before my next review, and what signs mean I should go straight to emergency care?
• Should I keep taking my usual inhalers, and is there anything I should pause?
• When will you review me, and do you want a follow-up sputum sample after the course?
• Is this my first, second or third flare this year, and does the count change my long-term plan?
• Would a physiotherapy review or a pulmonary rehabilitation referral help once I have recovered?

Bring a rough diary if you can: when the sputum changed, how much you are producing, what you can and cannot do compared with a fortnight ago, and any temperature readings. Teams make better decisions with specifics than with impressions, and a diary also protects you from the tendency to understate symptoms once you are sitting in a clinic and feeling slightly better than you did at 3 a.m.

If a question cannot be answered on the day, ask who will follow it up and when. Bronchiectasis care is long-term, and the relationship with your team is the most durable tool you have.

When to call your doctor

The threshold for contacting your respiratory team during a flare should be low. Guidelines expect that a change in treatment is a clinical decision, which means your team needs to hear about a sustained change in symptoms early rather than after a week of hoping. Contact them, or use your agreed self-management plan, when three or more of your key symptoms have worsened for two days or more: cough, sputum volume or thickness, sputum color, breathlessness or exercise tolerance, fatigue, or blood in sputum. Call again if you have started treatment and are not improving after the first several days, or if you improve and then slide back before the course is finished.

Some signs should not wait for a routine call. Seek emergency care immediately, by calling emergency services if needed, if any of the following appear:

• Severe breathlessness at rest, or breathing that is fast and shallow and not settling
• Bluish or gray color of the lips, tongue or fingertips
• New confusion, unusual drowsiness or difficulty staying awake
• Coughing up a large volume of blood, described by the NHS as more than 100 milliliters in 24 hours, or any bleeding accompanied by dizziness, faintness or worsening breathlessness
• Chest pain that is severe, crushing or spreading to the arm, jaw or back
• A temperature of 38°C (100.4°F) or higher that persists, especially with a racing pulse, cold clammy skin or feeling faint
• Being unable to eat, drink, take your medicines or complete airway clearance because of breathlessness or exhaustion

These features reflect the hospital admission criteria in respiratory guidelines and the NHS advice on serious bleeding. They are not a complete list of everything that can go wrong, and they do not replace your own team’s instructions, which may set different thresholds based on your baseline oxygen levels or other conditions. If you are unsure whether something is an emergency, that uncertainty is itself a reason to seek urgent advice rather than to wait. Every decision about what happens next, from antibiotic choice to whether you stay in hospital, rests with the clinicians assessing you.

Frequently asked questions

How long do bronchiectasis flare-ups last?

An uncomplicated flare is typically treated over 14 days, the antibiotic duration recommended by the British Thoracic Society and European Respiratory Society guidelines, with sputum usually improving before breathlessness and fatigue do. Guidelines do not set a fixed time for returning to baseline, and stamina can lag for weeks after the infection settles. A flare that is not improving within the first several days of treatment should be reported to your team.

What is a typical bronchiectasis flare up duration compared with a normal chest infection?

Longer. Many routine chest infections are treated for about a week, whereas bronchiectasis exacerbations are treated for 14 days in the major respiratory guidelines. The difference reflects the damaged, mucus-filled airways, which antibiotics penetrate poorly and in which bacteria rebound quickly if treatment stops early. Recovery of energy and exercise tolerance also tends to trail the end of the antibiotic course.

What does a bronchiectasis flare up feel like?

Most people describe sputum that darkens, thickens and increases in volume, a more frequent and tiring cough, breathlessness on tasks that were recently manageable, and deep fatigue that sleep does not fix. Fever is possible but not universal. Streaks of blood in sputum can appear. Only a clinician can confirm that a change meets the guideline definition of an exacerbation, so report sustained changes rather than trying to diagnose yourself.

What are the most common bronchiectasis exacerbation triggers?

Viral respiratory infections such as colds, influenza, RSV and COVID-19 are the most frequently reported trigger, because they inflame the airway lining and let resident bacteria multiply. Other triggers include lapses in daily airway clearance, dehydration, smoke and pollution, reflux, and shifts in colonizing bacteria, particularly Pseudomonas aeruginosa. Identifying your own pattern helps your team tailor a self-management plan.

How to stop bronchiectasis from getting worse between flares?

Daily airway clearance, annual influenza and pneumococcal vaccination as recommended by the NHS, treating any identified underlying cause, and pulmonary rehabilitation where breathlessness limits activity all have guideline support. For people with three or more exacerbations a year despite these measures, the British Thoracic Society guideline supports specialist discussion of long-term antibiotic strategies, which carry trade-offs and belong to the prescribing team.

Do I need antibiotics every time my sputum turns green?

Not necessarily. Sputum color is one clue, but the guideline definition of an exacerbation requires three or more key symptoms to worsen for at least 48 hours, and some people have discolored sputum at baseline from chronic colonization. Treating every color change with antibiotics drives resistance. Report sustained changes across several symptoms and let your team decide whether treatment is needed.

Why is a sputum sample taken before antibiotics start?

Because antibiotics can suppress bacterial growth in the laboratory and produce a misleadingly clean result. The British Thoracic Society guideline advises sending a sputum culture before the first dose so that if the empirical antibiotic does not work, the second choice is guided by which organism is present and what it is sensitive to. The sample does not delay treatment; antibiotics are started while the culture is processed.

Will steroids help a bronchiectasis flare-up?

For bronchiectasis on its own, respiratory guidelines do not recommend routine oral or inhaled corticosteroids during exacerbations, because the inflammation is driven by bacteria and steroids do not address that cause. The exception is coexisting asthma or COPD, where a flare of that condition may warrant steroids on its own merits. Your team decides which condition is driving the current episode.

Is coughing up blood during a flare an emergency?

Small streaks of blood in sputum are common during flares because inflamed airway walls bleed easily, and they usually settle with treatment. Large-volume bleeding is different: the NHS describes more than 100 milliliters in 24 hours as massive hemoptysis and advises calling emergency services. Bleeding accompanied by dizziness, faintness or worsening breathlessness should be treated as an emergency regardless of the amount.

Can a bronchiectasis flare-up be treated at home?

Most are. Home treatment with oral antibiotics and intensified airway clearance is the usual pathway when a person is comfortable at rest, alert, able to eat, drink and clear their airways, and improving on treatment. Hospital assessment is prompted by features in the British Thoracic Society criteria such as breathlessness at rest, a breathing rate of 25 or more, cyanosis, confusion, high fever or failure of oral antibiotics.

References

• NHS: Bronchiectasis
• Cleveland Clinic: Bronchiectasis
• MedlinePlus Medical Encyclopedia: Bronchiectasis
• NIH National Heart, Lung, and Blood Institute: Bronchiectasis

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.